[1] |
Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma[J]. Clin Oncol, 2005, 23(9): 2038-2048.
|
[2] |
Akgul O, Cetinkaya E, Ersoz S, et al. Role of surgery in colorectal cancer liver metastases[J]. World J Gastroenterol, 2014, 20(20): 6113-6122.
|
[3] |
Massmann A, Rodt T, Marquardt S, et al. Transarterial chemoembolization (TACE) for colorectal liver metastases—current status and critical review[J]. Langenbecks Arch Surg, 2015, 400(6): 641-659.
|
[4] |
刘海宽, 陈文川, 刘一铭, 等. 肝动脉栓塞术治疗42例低-中级别乏血供型神经内分泌肿瘤肝转移的近期疗效及安全性分析[J]. 中华介入放射学电子杂志, 2020, 8(2): 130-134.
|
[5] |
张超, 李非, 李昂, 等. 肝动脉化疗栓塞治疗原发病灶切除的胰腺神经内分泌肿瘤肝转移疗效分析[J]. 介入放射学杂志,2020, 29(8): 772-776.
|
[6] |
王舒婷, 陈海波, 施昌盛, 等. 经皮射频消融联合125I放射性粒子植入术治疗肝恶性肿瘤的疗效分析[J]. 介入放射学杂志, 2020, 29(6): 587-590.
|
[7] |
Galanakis N, Kehagias E, Matthaiou N, et al. Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review[J]. Hepat Oncol, 2018, 5(2): HEP07.
|
[8] |
Xu Z, Xie H, Zhou L, et al. The combination strategy of transarterial chemoembolization and radiofrequency ablation or microwave ablation against hepatocellular carcinoma[J]. Anal Cell Pathol (Amst), 2019, 2019: 8619096.
|
[9] |
Wu ZB, Si ZM, Qian S, et al. Percutaneous microwave ablation combined with synchronous transcatheter arterial chemoembolization for the treatment of colorectal liver metastases: results from a follow-up cohort[J]. OncoTargets Ther, 2016, 9: 3783-3789.
|
[10] |
许伟, 顾玉明, 王兴田, 等. 超声造影引导下微波消融联合TACE治疗肝转移瘤[J]. 介入放射学杂志, 2012, 21(10): 821-824.
|
[11] |
Vogl TJ, Lahrsow M, Albrecht MH, et al. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation[J]. Eur J Radiol, 2018, 102: 138-145.
|
[12] |
Nathan H, de Jong MC, Pulitano C, et al. Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients[J]. Am Coll Surg, 2010, 210(5): 755-764.
|
[13] |
Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea[J]. Stat Med, 2006, 25(1): 127-141.
|
[14] |
Sasaki K, Morioka D, Conci S, et al. The tumor burden score:a new "Metro-ticket" prognostic tool for colorectal liver metastases based on tumor size and number of tumors[J]. Ann Surg, 2018, 267(1): 132-141.
|
[15] |
王言焱, 刘佳明, 王立军, 等. 肿瘤负荷评分在肝细胞癌患者预后预测中的价值[J]. 中国癌症防治杂志, 2019, 11(5): 393-397.
|
[16] |
Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma[J]. Semin Liver Dis, 2010, 30(1): 52-60.
|
[17] |
Gruber-Rouh T, Marko C, Thalhammer A, et al. Current strategies in interventional oncology of colorectal liver metastases[J]. Br J Radiol, 2016, 89(1064): 20151060.
|
[18] |
Vogl TJ, Gruber-Rouh T, Eichler K, et al. Repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results[J]. Eur J Radiol, 2013, 82(2): 258-263.
|
[19] |
Zhang H, Guo J, Gao S, et al. Prognostic factors for transarterial chemoembolization combined with sustained oxaliplatin-based hepatic arterial infusion chemotherapy of colorectal cancer liver metastasis[J]. Chin J Cancer Res, 2017, 29(1): 36-44.
|